Hyperkinetic Movement Disorders

Also known as: Dyskinetic event / Dyskinesia / Dyskinesias / Dyskinetic movements / Dystonia, unspecified / Dyskinetic syndrome / Syndrome dyskinetic / Dyskinesia (finding) / Dystonia / Oral Dyskinesia / Oral dyskinesia (disorder)

DrugDrug NameDrug Description
DB00915AmantadineA medication used to treat dyskinesia in Parkinson's patients receiving levodopa, as well as extrapyramidal side effects of medications.
DB13844PipenzolateAn antimuscarinic agent indicated in the treatment of gastrointestinal motility disorders and arrhythmia.
DrugDrug NamePhaseStatusCount
DB00490Buspirone1Terminated1
DB04982Talampanel1 / 2Completed1
DB00514Dextromethorphan2Completed1
DB12883Eltoprazine2Unknown Status1
DB00927Famotidine2Completed1
DB01221Ketamine2Suspended1
DB01235Levodopa2Completed2
DB13004Mavoglurant2Completed4
DB00683Midazolam2Suspended1
DB05316Pimavanserin2Completed1
DB00908Quinidine2Completed1
DB06454Sarizotan2Completed1
DB04982Talampanel2Completed1
DB00915Amantadine2 / 3Completed1
DB12733Dipraglurant2 / 3Recruiting2
DB00915Amantadine3Completed3
DB00190Carbidopa3Completed1
DB01235Levodopa3Completed1
DB00268Ropinirole3Completed1
DB06454Sarizotan3Completed2
DB11915Valbenazine3Recruiting1
DB00190Carbidopa4Completed1
DB00159Icosapent4Completed1
DB01235Levodopa4Completed1
DB00909Zonisamide4Suspended1
DB01235LevodopaNot AvailableCompleted1
DB04844TetrabenazineNot AvailableNo Longer Available1